NCT01355614View on ClinicalTrials.gov

A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Crohn's Disease
Interventions
DRUG

QAX576

DRUG

Infliximab

Trial Locations (6)

8091

Novartis Investigative Site, Zurich

12203

Novartis Investigative Site, Berlin

13353

Novartis Investigative Site, Berlin

24105

Novartis Investigative Site, Kiel

93053

Novartis Investigative Site, München

07740

Novartis Investigative Site, Jena

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY